Liaoning Nirvana Pharmaceutical

Liaoning Nirvana Pharmaceutical (officially registered as Liaoning Nuoweinuo Pharmaceutical) is a commercial-stage pharmaceutical company established in 2008 and based in the Benxi High-Tech Industrial Development Zone, Liaoning Province, China. The company specializes in the research, development, manufacturing, and commercialization of active pharmaceutical ingredients (APIs) and finished dosage forms, with a strong focus on gastroenterology, endocrinology, and infectious diseases. Its product portfolio includes pantoprazole sodium (a proton pump inhibitor), octreotide acetate, ganciclovir, and olsalazine sodium. Operating from a modern, GMP-certified facility, the company produces freeze-dried powder injections, small-volume injections, tablets, capsules, and granules for both domestic and international markets.